See more : Nextronics Engineering Corp. (8147.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of DATATRAK International, Inc. (DTRK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of DATATRAK International, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
You may be interested
- Cascadia Acquisition Corp. (CCAIU) Income Statement Analysis – Financial Results
- Precision BioSciences, Inc. (DTIL) Income Statement Analysis – Financial Results
- Federal Home Loan Mortgage Corporation (FMCCJ) Income Statement Analysis – Financial Results
- Danske Invest Fjernøsten Indeks (DKIFJIX.CO) Income Statement Analysis – Financial Results
- CA Cultural Technology Group Limited (1566.HK) Income Statement Analysis – Financial Results
DATATRAK International, Inc. (DTRK)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.datatrak.com
About DATATRAK International, Inc.
DATATRAK International, Inc., a technology and services company, provides unified clinical solutions and related services for the clinical trials industry. The company offers DATATRAK ONE Unified Experience, a clinical enterprise solution that allows clinical users and service providers to design, deliver, and manage clinical trials. Its products include UX CTMS 360 for planning and managing trials; UX Trial to streamline design-to-deployment process using a tool; UX EDC & Medical Coding for capturing and delivering data; UX Randomization and Trial Supply Management to randomize patients and automate supply; UX Patient Data Capture; UX Safety; and UX Training to train users and track certificates. The company also provides DATATRAK Clinical Consulting Services, such as training, support, learning center, Software as a Service hosting, standards, and trial design services. It serves contract research organizations, pharma and biotech companies, and clinical trial device companies. DATATRAK International, Inc. was founded in 1991 and is headquartered in Mayfield Heights, Ohio.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.18M | 5.93M | 6.38M | 7.16M | 7.74M | 7.45M | 7.52M | 8.98M | 9.96M | 11.01M | 10.90M | 9.72M | 8.83M | 10.56M | 17.69M | 15.73M | 11.31M | 7.05M | 4.72M | 2.25M | 1.99M | 5.81M | 13.20M | 17.30M | 25.70M | 10.50M |
| Cost of Revenue | 1.04M | 2.25M | 2.20M | 1.94M | 2.22M | 2.07M | 2.02M | 1.86M | 2.27M | 2.20M | 2.01M | 1.65M | 2.83M | 4.58M | 5.22M | 3.79M | 2.63M | 1.62M | 1.80M | 1.78M | 1.60M | 4.02M | 10.50M | 12.60M | 18.00M | 8.50M |
| Gross Profit | 5.15M | 3.68M | 4.18M | 5.22M | 5.52M | 5.37M | 5.50M | 7.13M | 7.69M | 8.81M | 8.89M | 8.07M | 5.99M | 5.98M | 12.47M | 11.95M | 8.67M | 5.43M | 2.92M | 466.13K | 397.43K | 1.79M | 2.70M | 4.70M | 7.70M | 2.00M |
| Gross Profit Ratio | 83.23% | 62.03% | 65.54% | 72.90% | 71.28% | 72.14% | 73.09% | 79.32% | 77.23% | 80.02% | 81.59% | 83.05% | 67.90% | 56.61% | 70.48% | 75.92% | 76.70% | 77.00% | 61.79% | 20.76% | 19.93% | 30.74% | 20.45% | 27.17% | 29.96% | 19.05% |
| Research & Development | 0.00 | 0.00 | 993.00K | 1.08M | 1.04M | 1.17M | 1.29M | 884.00K | 1.29M | 0.00 | 1.61K | 1.45K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.01M | 9.71M | 9.44M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 401.00 | 304.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.27M | 5.15M | 4.33M | 4.23M | 4.10M | 4.04M | 3.99M | 5.16M | 9.29M | 10.01M | 9.71M | 9.44M | 10.18M | 13.10M | 13.27M | 10.03M | 7.23M | 5.55M | 7.89M | 7.21M | 5.73M | 5.61M | 9.00M | 10.00M | 6.10M | 2.80M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 81.80K | 59.89K | 156.60K | 1.34M | 2.94M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 3.27M | 5.15M | 5.33M | 5.31M | 5.14M | 5.21M | 5.29M | 6.04M | 10.57M | 10.09M | 9.77M | 9.60M | 11.52M | 16.03M | 15.57M | 10.77M | 7.88M | 6.49M | 9.38M | 8.16M | 6.59M | 6.41M | 10.20M | 11.00M | 6.70M | 2.90M |
| Cost & Expenses | 4.31M | 7.40M | 7.53M | 7.25M | 7.37M | 7.29M | 7.31M | 7.90M | 12.84M | 12.29M | 11.77M | 11.25M | 14.35M | 20.61M | 20.79M | 14.56M | 10.51M | 8.11M | 11.18M | 9.94M | 8.19M | 10.43M | 20.70M | 23.60M | 24.70M | 11.40M |
| Interest Income | 19.99K | 59.02K | 48.24K | 5.02K | 18.14K | 0.25 | 127.20 | 47.30 | 12.42 | 1.41K | 3.96K | 539.00 | 115.97K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 37.29K | 2.03K | 8.51K | 3.80K | 0.00 | 0.00 | 0.00 | 0.00 | 14.02K | 9.48K | 10.68K | 34.04K | 369.76K | 352.87K | 0.00 | 203.00 | 6.70K | 17.35K | 19.49K | 0.00 | 0.00 | 0.00 | 0.00 | 100.00K | 0.00 |
| Depreciation & Amortization | 67.05K | -186.07K | 873.50K | 764.85K | 1.05M | 681.01K | 634.97K | 253.47K | 189.86K | 83.20K | 63.85K | 157.14K | 4.46M | 3.85M | 2.31M | 748.36K | 650.96K | 936.96K | 1.12M | 949.77K | 867.48K | 800.50K | 1.20M | 1.00M | 600.00K | 100.00K |
| EBITDA | 2.73M | -1.04M | 625.64K | 683.18K | 1.44M | 841.74K | 845.30K | 1.34M | -2.69M | -1.20M | -59.53K | -1.37M | -15.03M | -7.12M | -855.16K | 1.92M | 1.44M | -120.91K | -5.34M | -6.74M | -5.33M | -3.82M | -6.30M | -5.27M | 1.60M | -800.00K |
| EBITDA Ratio | 44.12% | -28.04% | -4.26% | 9.43% | 18.39% | 11.30% | 11.26% | 14.88% | -27.04% | -10.87% | -7.43% | -14.12% | -12.12% | -58.71% | -2.84% | 12.60% | 12.83% | -1.64% | -105.40% | -299.24% | -268.44% | -296.60% | 2.27% | -24.28% | 1.95% | -8.57% |
| Operating Income | 1.88M | -1.48M | -1.15M | -90.05K | 373.91K | 160.72K | 212.21K | 1.08M | -2.88M | -1.28M | -873.38K | -1.53M | -5.53M | -10.05M | -3.40M | 1.17M | 790.91K | -1.06M | -6.46M | -7.69M | -6.20M | -4.62M | -7.50M | -6.30M | 1.00M | -900.00K |
| Operating Income Ratio | 30.38% | -24.90% | -17.95% | -1.26% | 4.83% | 2.16% | 2.82% | 12.05% | -28.95% | -11.63% | -8.01% | -15.74% | -62.64% | -95.18% | -19.22% | 7.45% | 7.00% | -15.00% | -136.89% | -342.60% | -310.76% | -79.55% | -56.82% | -36.42% | 3.89% | -8.57% |
| Total Other Income/Expenses | 778.56K | 587.08K | 895.42K | -140.00 | 12.89K | 850.00 | -127.20K | -53.32K | -15.73K | -12.61K | 744.48K | -11.52K | -10.88M | -846.41K | -115.11K | 182.41K | 34.62K | 13.56K | -363.96K | 339.20K | 23.77K | 14.73M | -6.50M | -1.23M | 1.00M | 100.00K |
| Income Before Tax | 2.66M | -888.57K | -249.88K | -90.19K | 386.80K | 161.58K | 85.01K | 1.03M | -2.90M | -1.29M | -128.90K | -1.54M | -16.41M | -10.90M | -3.51M | 1.36M | 825.53K | -1.04M | -6.83M | -7.35M | -6.17M | 10.10M | -14.00M | -7.50M | 2.00M | -800.00K |
| Income Before Tax Ratio | 42.97% | -15.00% | -3.92% | -1.26% | 5.00% | 2.17% | 1.13% | 11.46% | -29.11% | -11.74% | -1.18% | -15.84% | -185.94% | -103.20% | -19.87% | 8.61% | 7.30% | -14.81% | -144.60% | -327.49% | -309.57% | 173.86% | -106.06% | -43.35% | 7.78% | -7.62% |
| Income Tax Expense | 56.00 | -3.00 | 2.00 | -1.00 | 4.00 | -1.00 | -134.69K | 12.64K | -3.00 | 14.02K | 9.48K | 10.68K | 385.00K | -46.00K | 976.00K | -1.18M | 8.50K | 4.32K | -71.85K | -339.20K | -912.15K | 384.00K | 100.00K | -100.00K | 400.00K | -100.00K |
| Net Income | 2.66M | -888.57K | -249.88K | -90.19K | 386.80K | 161.58K | 219.70K | 1.02M | -2.90M | -1.31M | -138.38K | -1.55M | -16.80M | -10.85M | -4.49M | 2.54M | 817.03K | -1.05M | -6.39M | -7.35M | -5.28M | 9.72M | -14.10M | -7.40M | 1.60M | -800.00K |
| Net Income Ratio | 42.97% | -15.00% | -3.92% | -1.26% | 5.00% | 2.17% | 2.92% | 11.32% | -29.11% | -11.87% | -1.27% | -15.95% | -190.31% | -102.76% | -25.38% | 16.13% | 7.23% | -14.87% | -135.37% | -327.49% | -265.01% | 167.26% | -106.82% | -42.77% | 6.23% | -7.62% |
| EPS | 0.47 | -0.32 | -0.10 | -0.04 | 0.16 | 0.07 | 0.11 | 0.60 | -1.93 | -0.91 | -0.10 | -1.22 | -14.73 | -9.87 | -4.78 | 3.00 | 1.08 | -1.51 | -9.76 | -17.88 | -12.85 | 14.96 | -17.57 | -9.28 | 2.88 | -2.48 |
| EPS Diluted | 0.47 | -0.32 | -0.10 | -0.04 | 0.16 | 0.07 | 0.11 | 0.55 | -1.93 | -0.91 | -0.10 | -1.22 | -14.73 | -9.87 | -4.78 | 2.64 | 0.96 | -1.51 | -9.76 | -17.88 | -12.85 | 14.72 | -17.57 | -9.28 | 2.64 | -2.48 |
| Weighted Avg Shares Out | 5.67M | 2.81M | 2.42M | 2.39M | 2.35M | 2.30M | 1.95M | 1.68M | 1.50M | 1.43M | 1.35M | 1.27M | 1.14M | 1.10M | 939.44K | 850.30K | 762.42K | 695.64K | 654.68K | 411.31K | 411.29K | 651.06K | 802.72K | 797.01K | 555.28K | 322.42K |
| Weighted Avg Shares Out (Dil) | 5.67M | 2.81M | 2.42M | 2.39M | 2.38M | 2.33M | 2.00M | 1.83M | 1.50M | 1.43M | 1.35M | 1.27M | 1.14M | 1.10M | 939.44K | 948.86K | 853.12K | 695.64K | 654.68K | 411.31K | 411.29K | 661.68K | 802.72K | 797.01K | 605.76K | 322.42K |
Datatrak International, Inc. Discusses Potential of Its eClinicial and Predictive Analytics Platforms with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - September 22, 2021) - The Stock Day Podcast welcomed Datatrak International, Inc. (OTC Pink: DTRK) ("the Company"), a software-as-a-service provider of enterprise cloud-based technologies for the life sciences industry. CEO of the Company, Jim Bob Ward,...
Datatrak International, Inc. Reports Results for Second Quarter and First Half of 2021
CLEVELAND, OH, Aug. 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Datatrak International, Inc. (OTC Markets: DTRK), (“Datatrak” or the “Company”), a Software-as-a-Service (“SaaS”) provider of cloud-based technologies for the life sciences industry, today announced its operating results for the second...
Datatrak International, Inc. Reports First Quarter Results for 2021
CLEVELAND, OH, May 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Datatrak International, Inc. (OTC Markets: DTRK), (“Datatrak” or the “Company”), a worldwide Software-as-a-Service (“SaaS”) provider and innovation leader of cloud-based technologies for the life sciences industry, today announced its operating...
Datatrak International Launches ePRO, eCOA and eConsent Solution to Support the Advancement of Decentralized Trials Globally
CLEVELAND, OH, April 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Datatrak International, Inc. (OTC Markets: DTRK), a worldwide Software-as-a-Service (“SaaS”) provider and innovation leader of cloud-based technologies for the life sciences industry, is proud to announce that Datatrak Direct, an all...
Source: https://incomestatements.info
Category: Stock Reports